Literature DB >> 28414098

Cytosolic calcium mediates RIP1/RIP3 complex-dependent necroptosis through JNK activation and mitochondrial ROS production in human colon cancer cells.

Wen Sun1, Xiaxia Wu1, Hongwei Gao1, Jie Yu1, Wenwen Zhao1, Jin-Jian Lu1, Jinhua Wang2, Guanhua Du2, Xiuping Chen3.   

Abstract

Necroptosis is a form of programmed necrosis mediated by signaling complexes with receptor-interacting protein 1 (RIP1) and RIP3 kinases as the main mediators. However, the underlying execution pathways of this phenomenon have yet to be elucidated in detail. In this study, a RIP1/RIP3 complex was formed in 2-methoxy-6-acetyl-7-methyljuglone (MAM)-treated HCT116 and HT29 colon cancer cells. With this formation, mitochondrial reactive oxygen species (ROS) levels increased, mitochondrial depolarization occurred, and ATP concentrations decreased. This process was identified as necroptosis. This finding was confirmed by experiments showing that MAM-induced cell death was attenuated by the pharmacological or genetic blockage of necroptosis signaling, including RIP1 inhibitor necrostatin-1s (Nec-1s) and siRNA-mediated gene silencing of RIP1 and RIP3, but was unaffected by caspase inhibitor z-vad-fmk or necrosis inhibitor 2-(1H-Indol-3-yl)-3-pentylamino-maleimide (IM54). Transmission electron microscopy (TEM) analysis further revealed the ultrastructural features of MAM-induced necroptosis. MAM-induced RIP1/RIP3 complex triggered necroptosis through cytosolic calcium (Ca2+) accumulation and sustained c-Jun N-terminal kinase (JNK) activation. Both calcium chelator BAPTA-AM and JNK inhibitor SP600125 could attenuate necroptotic features, including mitochondrial ROS elevation, mitochondrial depolarization, and ATP depletion. 2-thenoyltrifluoroacetone (TTFA), which is a mitochondrial complex II inhibitor, was found to effectively reverse both MAM induced mitochondrial ROS generation and cell death, indicating the complex II was the ROS-producing site. The essential role of mitochondrial ROS was confirmed by the protective effect of overexpression of manganese superoxide dismutase (MnSOD). MAM-induced necroptosis was independent of TNFα, p53, MLKL, and lysosomal membrane permeabilization. In summary, our study demonstrated that RIP1/RIP3 complex-triggered cytosolic calcium accumulation is a critical mediator in MAM-induced necroptosis through sustained JNK activation and mitochondrial ROS production. Our study also provided new insights into the molecular regulation of necroptosis in human colon cancer cells.
Copyright © 2017 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Calcium; Necroptosis; ROS; c-Jun N-terminal kinase

Mesh:

Substances:

Year:  2017        PMID: 28414098     DOI: 10.1016/j.freeradbiomed.2017.04.010

Source DB:  PubMed          Journal:  Free Radic Biol Med        ISSN: 0891-5849            Impact factor:   7.376


  29 in total

1.  Upregulation of human glycolipid transfer protein (GLTP) induces necroptosis in colon carcinoma cells.

Authors:  Shrawan Kumar Mishra; Daniel J Stephenson; Charles E Chalfant; Rhoderick E Brown
Journal:  Biochim Biophys Acta Mol Cell Biol Lipids       Date:  2018-11-22       Impact factor: 4.698

2.  Mitochondria Permeability Transition versus Necroptosis in Oxalate-Induced AKI.

Authors:  Shrikant Ramesh Mulay; Mohsen M Honarpisheh; Orestes Foresto-Neto; Chongxu Shi; Jyaysi Desai; Zhi Bo Zhao; Julian A Marschner; Bastian Popper; Ewa Miriam Buhl; Peter Boor; Andreas Linkermann; Helen Liapis; Rostyslav Bilyy; Martin Herrmann; Paola Romagnani; Ilya Belevich; Eija Jokitalo; Jan U Becker; Hans-Joachim Anders
Journal:  J Am Soc Nephrol       Date:  2019-07-11       Impact factor: 10.121

3.  Biological events and molecular signaling following MLKL activation during necroptosis.

Authors:  Yi-Nan Gong; Cliff Guy; Jeremy Chase Crawford; Douglas R Green
Journal:  Cell Cycle       Date:  2017-08-30       Impact factor: 4.534

4.  Selenium Deficiency Induces Apoptosis and Necroptosis Through ROS/MAPK Signal in Human Uterine Smooth Muscle Cells.

Authors:  Yueyang Wang; Xiaojing Li; Yujie Yao; Xia Zhao; Xu Shi; Yan Cai
Journal:  Biol Trace Elem Res       Date:  2021-09-04       Impact factor: 3.738

Review 5.  The regulation of necroptosis and perspectives for the development of new drugs preventing ischemic/reperfusion of cardiac injury.

Authors:  Leonid N Maslov; Sergey V Popov; Natalia V Naryzhnaya; Alexandr V Mukhomedzyanov; Boris K Kurbatov; Ivan A Derkachev; Alla A Boshchenko; Igor Khaliulin; N Rajendra Prasad; Nirmal Singh; Alexei Degterev; Evgenia A Tomilova; Ekaterina V Sapozhenkova
Journal:  Apoptosis       Date:  2022-08-20       Impact factor: 5.561

6.  JNK activation and translocation to mitochondria mediates mitochondrial dysfunction and cell death induced by VDAC opening and sorafenib in hepatocarcinoma cells.

Authors:  K A Heslop; A Rovini; E G Hunt; D Fang; M E Morris; C F Christie; M B Gooz; D N DeHart; Y Dang; J J Lemasters; E N Maldonado
Journal:  Biochem Pharmacol       Date:  2019-11-21       Impact factor: 5.858

7.  EZH2 Regulates Intestinal Inflammation and Necroptosis Through the JNK Signaling Pathway in Intestinal Epithelial Cells.

Authors:  Xinhe Lou; Huatuo Zhu; Longgui Ning; Chunxiao Li; Sha Li; Haojie Du; Xinxin Zhou; Guoqiang Xu
Journal:  Dig Dis Sci       Date:  2019-07-04       Impact factor: 3.199

Review 8.  Mechanistic connections between mitochondrial biology and regulated cell death.

Authors:  Jerry Edward Chipuk; Jarvier N Mohammed; Jesse D Gelles; Yiyang Chen
Journal:  Dev Cell       Date:  2021-04-21       Impact factor: 12.270

9.  Predicted molecular targets and pathways for germacrone, curdione, and furanodiene in the treatment of breast cancer using a bioinformatics approach.

Authors:  Qi Kong; Yong Ma; Jie Yu; Xiuping Chen
Journal:  Sci Rep       Date:  2017-11-14       Impact factor: 4.379

Review 10.  Receptor-interacting protein in malignant digestive neoplasms.

Authors:  Lilong Zhang; Wenyi Guo; Jia Yu; Chunlei Li; Man Li; Dongqi Chai; Weixing Wang; Wenhong Deng
Journal:  J Cancer       Date:  2021-05-19       Impact factor: 4.207

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.